Statement of Changes in Beneficial Ownership (4)
13 May 2015 - 8:51AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Ushio Misti
|
2. Issuer Name
and
Ticker or Trading Symbol
OPGEN INC
[
OPGN,OPGNW
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
1450 BROADWAY 24TH FLOOR
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
5/8/2015
|
(Street)
NEW YORK, NY 10018
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
5/8/2015
|
|
P
|
|
300833
|
A
|
$6.00
|
330716
|
I
|
See footnote
(4)
|
Common Stock
|
5/8/2015
|
|
C
|
|
610017
|
A
|
(1)
|
940733
|
I
|
See footnote
(4)
|
Common Stock
|
5/8/2015
|
|
C
|
|
209020
|
A
|
(2)
|
1149753
|
I
|
See footnote
(4)
|
Common Stock
|
5/8/2015
|
|
C
|
|
260043
|
A
|
(3)
|
1409796
|
I
|
See footnote
(4)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Series A Redeemable Convertible Preferred Stock
|
(1)
|
5/8/2015
|
|
C
|
|
|
610017
|
(1)
|
(1)
|
Common Stock
|
610017
|
$0.00
|
0
|
I
|
See footnote
(4)
|
2014 Convertible Notes
|
(2)
|
5/8/2015
|
|
C
|
|
|
209020
|
(2)
|
(2)
|
Common Stock
|
209020
|
$0.00
|
0
|
I
|
See footnote
(4)
|
2015 Convertible Notes
|
(3)
|
5/8/2015
|
|
C
|
|
|
260043
|
(3)
|
(3)
|
Common Stock
|
260043
|
$0.00
|
0
|
I
|
See footnote
(4)
|
Warrants
|
$6.60
|
5/8/2015
|
|
P
|
|
300833
|
|
5/8/2015
|
5/8/2020
|
Common Stock
|
300833
|
$0.00
|
300833
|
I
|
See footnote
(4)
|
Explanation of Responses:
|
(
1)
|
Series A Redeemable Convertible Preferred Stock automatically converted into common stock on a 1-to-1 basis upon the consummation of the Company's initial public offering.
|
(
2)
|
The 2014 Convertible Notes automatically converted into shares of Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of one share of Series A Preferred Stock for every $1.00 of principal converted. Each share of Series A Preferred Stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
|
(
3)
|
The 2015 Convertible Notes converted into Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of 1.25 shares of Series A Preferred Stock for each $1.00 of principal converted. Each share of Series A Preferred stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
|
(
4)
|
The securities are directly held by Harris & Harris Group, Inc. Dr. Ushio is Chief Strategy Officer and Managing Director of Harris & Harris Group, Inc., and may be deemed to have shared voting power over the shares owned by Harris & Harris Group, Inc. Dr. Ushio disclaims beneficial ownership of all shares held by Harris & Harris Group, Inc., except to the extent of her actual pecuniary interest therein.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Ushio Misti
1450 BROADWAY 24TH FLOOR
NEW YORK, NY 10018
|
X
|
|
|
|
Signatures
|
/s/ Timothy C. Dec, Attorney-in-Fact
|
|
5/12/2015
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2024 to Oct 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Oct 2023 to Oct 2024